| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.074 | 0.6 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.083 | 0.6 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.067 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |